Global Breast Biopsy Needle Market Growth 2025-2031

The global Breast Biopsy Needle market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Breast Biopsy is a procedure in which a sample of a suspicious breast growth is removed and examined, usually for the presence of cancer. The sample is suctioned out through a needle or removed surgically. A breast biopsy is the best way to evaluate if a suspicious lump or portion of your breast is cancerous.

United States market for Breast Biopsy Needle is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Breast Biopsy Needle is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Breast Biopsy Needle is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Breast Biopsy Needle players cover Mammotome, Hologic, C.R Bard, BD, Stryker, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Breast Biopsy Needle Industry Forecast” looks at past sales and reviews total world Breast Biopsy Needle sales in 2024, providing a comprehensive analysis by region and market sector of projected Breast Biopsy Needle sales for 2025 through 2031. With Breast Biopsy Needle sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Breast Biopsy Needle industry.

This Insight Report provides a comprehensive analysis of the global Breast Biopsy Needle landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Breast Biopsy Needle portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Breast Biopsy Needle market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Breast Biopsy Needle and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Breast Biopsy Needle.

This report presents a comprehensive overview, market shares, and growth opportunities of Breast Biopsy Needle market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Needle Based Biopsy
Surgical Biopsy

Segmentation by Application:
Hospital
Clinic

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Mammotome
Hologic
C.R Bard
BD
Stryker
Galini SRL
Medtronic

Key Questions Addressed in this Report

What is the 10-year outlook for the global Breast Biopsy Needle market?

What factors are driving Breast Biopsy Needle market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Breast Biopsy Needle market opportunities vary by end market size?

How does Breast Biopsy Needle break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.